Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Completed · Phase 3

Conditions studied: Skin Diseases, Bacterial

In brief

The study is now completed

Key facts

Study ID

NCT00303550

Run by

Arpida AG

Starts

2006-03-01

Last updated by the study team

2007-03-27

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of an infection consistent with complicated skin and skin structure infection due to a gram positive pathogen.

You may not qualify if…

• Known or suspected hypersensitivity to any study medication or other related anti-infective medication
• Any known or suspected condition or concurrent treatment contraindicated by the prescribing information
• Previous enrollment in this study
• Treatment with any investigational drug within 30 days before enrollment

Where it is running

• Edward Hospital & Health Services — Naperville, Illinois, United States
• Wyoming Medical Center — Casper, Wyoming, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.